Genenta Science S.p.A.
GNTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,912 | -$11,645 | -$8,478 | -$5,529 |
| Dep. & Amort. | $45 | $42 | $6 | $5 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $847 | $740 | $723 | $497 |
| Change in WC | $1,717 | -$418 | $240 | -$1,944 |
| Other Non-Cash | $63 | $76 | $90 | $13 |
| Operating Cash Flow | -$6,240 | -$11,205 | -$7,418 | -$6,958 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4 | -$14 | -$27 | -$9 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$16,380 | -$14,574 | $0 | $0 |
| Inv. Sales/Matur. | $23,268 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$305 | $0 | $0 |
| Investing Cash Flow | $6,883 | -$14,893 | -$27 | -$9 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $1 | $0 | $28,742 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $271 | $0 | $0 | $1 |
| Financing Cash Flow | $271 | $1 | $0 | $28,742 |
| Forex Effect | -$23 | -$6 | $0 | $0 |
| Net Chg. in Cash | $890 | -$26,103 | -$7,445 | $21,775 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,691 | $29,795 | $37,240 | $15,465 |
| End Cash | $4,582 | $3,691 | $29,795 | $37,240 |
| Free Cash Flow | -$6,245 | -$11,219 | -$7,445 | -$6,967 |